AVNS profile · all as-reported value updates
AVANOS MEDICAL, INC. (AVNS) as-reported value updates
Descriptive filing record — not investment advice. This page compares two SEC XBRL-filed values for the same fiscal period. It does not state why the values differ and is not a rating, score, or recommendation. See Disclaimer.
Reported values for the same fiscal period can differ between filings for many routine reasons: re-presentation for discontinued operations, adoption of new accounting standards, reclassifications, changes in rounding precision, and amendments. This ledger records that the filed values differ; it does not and cannot determine why. Both filings are linked below so the reader can consult the source.
Ledger table figure
| Metric | FY | Earliest XBRL-filed value | Currently on file | Difference | Difference % | Label | Filing links | Notes |
|---|---|---|---|---|---|---|---|---|
| Operating income | 2016 | 87,400,000 | -107,100,000 | -194,500,000 | -181.61% | revised comparative figure | 0001606498-17-000008 0001606498-19-000018 | 3 filed observations examined for this concept and period. |
| Operating income | 2021 | 8,900,000 | -39,000,000 | -47,900,000 | -122.82% | revised comparative figure | 0001606498-22-000029 0001606498-24-000018 | 3 filed observations examined for this concept and period. |
| Operating income | 2022 | 74,000,000 | 35,500,000 | -38,500,000 | -52.03% | revised comparative figure | 0001606498-23-000020 0001606498-25-000024 | 3 filed observations examined for this concept and period. |
| Gross profit | 2016 | 557,900,000 | 297,200,000 | -260,700,000 | -46.73% | revised comparative figure | 0001606498-17-000008 0001606498-19-000018 | 3 filed observations examined for this concept and period. |
| Revenue | 2021 | 744,600,000 | 587,000,000 | -157,600,000 | -21.17% | revised comparative figure | 0001606498-22-000029 0001606498-24-000018 | 3 filed observations examined for this concept and period. |
| Gross profit | 2021 | 364,300,000 | 299,200,000 | -65,100,000 | -17.87% | revised comparative figure | 0001606498-22-000029 0001606498-24-000018 | 3 filed observations examined for this concept and period. |
| Net income | 2021 | 5,200,000 | 6,300,000 | 1,100,000 | +17.46% | revised comparative figure | 0001606498-22-000029 0001606498-24-000018 | 3 filed observations examined for this concept and period. |
| Revenue | 2022 | 820,000,000 | 684,100,000 | -135,900,000 | -16.57% | revised comparative figure | 0001606498-23-000020 0001606498-25-000024 | 3 filed observations examined for this concept and period. |
| Gross profit | 2022 | 450,000,000 | 394,200,000 | -55,800,000 | -12.40% | revised comparative figure | 0001606498-23-000020 0001606498-25-000024 | 3 filed observations examined for this concept and period. |
| Net income | 2020 | -27,200,000 | -29,000,000 | -1,800,000 | -6.21% | revised comparative figure | 0001606498-21-000015 0001606498-23-000020 | 3 filed observations examined for this concept and period. |
| Operating income | 2020 | -46,100,000 | -48,500,000 | -2,400,000 | -4.95% | revised comparative figure | 0001606498-21-000015 0001606498-23-000020 | 3 filed observations examined for this concept and period. |